Literature DB >> 18208440

Clinical features and mutational survey of NPHS2 (podocin) in Japanese children with focal segmental glomerulosclerosis who underwent renal transplantation.

Takeki Furue1, Motoshi Hattori, Hiroyasu Tsukaguchi, Akiko Kitamura, Tae Oomori, Daisuke Ogino, Hyogo Nakakura, Akira Ashida, Kenichiro Miura, Masataka Hisano, Kazuhiro Takahashi, Hiroko Chikamoto, Yuko Akioka, Takashi Sakano.   

Abstract

Recurrent FSGS is a major challenge in the field of nephrology. To clarify the role of NPHS2 defects in the pathogenesis of FSGS recurrence, we sequenced all eight exons of NPHS2 in 11 Japanese pediatric FSGS patients with or without post-transplant recurrence. All patients had biopsy-proven primary FSGS, had no family history of renal diseases or consanguinity, were steroid-resistant, and received living-related renal transplantation. The mean age at onset was 5.0 +/- 3.1 yr and mean age at renal transplantation was 10.4 +/- 4.1 yr. Mutational analysis of NPHS2 was performed using polymerase chain reaction and direct sequencing. We found a synonymous T/C polymorphism at alanine 318 (GCC to GCT) in seven of 11 patients but no other causative NPHS2 mutations. FSGS recurred immediately after transplant in seven patients, while the remaining four patients had no recurrence for 3.2-5.8 yr. There were no differences between recurrent and non-recurrent patients in the onset age and the interval from onset to ESRD. In conclusion, we detected no causative NPHS2 mutations in Japanese pediatric FSGS patients with or without post-transplant recurrence. Further studies on the involvement of other genes are required to better understand recurrent FSGS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18208440     DOI: 10.1111/j.1399-3046.2007.00752.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  4 in total

1.  Potential donor-recipient MYH9 genotype interactions in posttransplant nephrotic syndrome after pediatric kidney transplantation.

Authors:  B I Freedman; S K Nagaraj; J-J Lin; M D Gautreaux; D W Bowden; S S Iskandar; R J Stratta; J Rogers; E L Hartmann; A C Farney; A M Reeves-Daniel
Journal:  Am J Transplant       Date:  2009-10       Impact factor: 8.086

2.  Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis.

Authors:  Yutaka Harita; Kiyonobu Ishizuka; Atsushi Tanego; Noriko Sugawara; Hiroko Chikamoto; Yuko Akioka; Haruko Tsurumi; Kenichiro Miura; Yoshimitsu Gotoh; Makoto Tsujita; Takayuki Yamamoto; Keiji Horike; Asami Takeda; Akira Oka; Takashi Igarashi; Motoshi Hattori
Journal:  Pediatr Nephrol       Date:  2014-04-06       Impact factor: 3.714

3.  The expression of cytoskeletal proteins in kidney specimens of children with primary focal segmental glomerulosclerosis.

Authors:  A Gheissari; D Taheri; S Mozafarpour; H Beigy; P Samanianpoor; A Merrikhi; Z Farajzadegan
Journal:  Indian J Nephrol       Date:  2012-11

Review 4.  Application of next-generation sequencing technology to diagnosis and treatment of focal segmental glomerulosclerosis.

Authors:  Yutaka Harita
Journal:  Clin Exp Nephrol       Date:  2017-07-27       Impact factor: 2.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.